BAILEY SCOTT: Open Payments
NPI 1407581630 · BRIGHTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,221 in 40 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $291 · 2025 $1,221
Food & beverage: $1,221
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $324 |
| Endo USA, Inc. | 7 | $187 |
| Merck Sharp & Dohme LLC | 4 | $124 |
| Tempus AI, Inc | 3 | $91 |
| Ferring Pharmaceuticals Inc. | 3 | $73 |
| COLOPLAST CORP | 3 | $65 |
| Astellas Pharma US Inc | 2 | $51 |
| UROGEN PHARMA, INC. | 1 | $49 |
| Sumitomo Pharma America, Inc. | 1 | $44 |
| Telix Pharmaceuticals | 2 | $42 |
Products named: XIAFLEX, RYBREVANT, ERLEADA, XT CDX, Xtandi, ADSTILADRIN, Luja Coude, KEYTRUDA.
Industry payments across MA — which companies pay providers there.
